VPC-70619 is a potent, orally active and selective N-Myc inhibitor that inhibits cancer cell growth by blocking the binding of N-Myc-Max compounds to the E-box of DNA. It can be efficiently absorbed and utilized by the body through oral or intraperitoneal routes.